Visual Field Examination
J9 · Effective Oct 1, 2015
2 active Medicare policies list H44.20, and 2 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J9 · Effective Oct 1, 2015
J9 · Effective Oct 1, 2025
2 policies from 1 payer
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of H44.20 |
|---|---|---|
| Vascular Endothelial Growth Factor Inhibitors for Ocular Indications | Feb 20, 2024 | Covered |
| Verteporfin (Visudyne) Photodynamic Therapy | Jun 29, 2023 | Covered |